Dec 1, 2021
It’s time for the final episode of JHLT: The Podcast for 2021! Join Daniel R. Goldstein, MD, Editor-in-Chief of JHLT, and the JHLT Digital Media Editors for two interviews with authors from the December issue of The Journal of Heart and Lung Transplantation. Both studies focus on protein biomarkers in thoracic transplantation.
First, the editors
speak with Tereza Martinu, MD, MHS, Assistant
Professor and Clinician at Toronto General Hospital. Dr. Martinu is
the lead author on a paper entitled “Bronchoalveolar lavage
cytokine-based risk stratification of minimal acute rejection in
clinically stable lung transplant recipients.” Beginning
at 1:45, Erika Lease, MD, and David
Schibilsky, MD, interview Dr. Martinu about the findings
of the study and potential future application in clinical
settings.
Starting at 13:35,
Van-Khue Ton, MD, PhD, and Marty Tam,
MD, are in conversation with Lauren Truby,
MD, Cardiology Fellow at Duke University Medical Center,
about her study from the December issue: “Proteomic profiling identifies
CLEC4C expression as a novel biomarker of primary graft dysfunction
after heart transplantation.” Dr. Truby discusses her
team’s work on PGD, the expression of CLEC4C in transplant
patients, and future potential work in the field.
Follow along in the December issue at www.jhltonline.org/current, or, if you’re an ISHLT member, log in at ishlt.org/journal-of-heart-lung-transplantation. Don’t already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.
This episode of JHLT: The Podcast, but not the studies within, is sponsored by Paragonix.
